Study Evaluating Etanercept in Moderate to Severe Asthma
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to assess the efficacy and safety of etanercept 25 mg
given twice weekly in subjects with moderate to severe persistent asthma.